Distal Versus Conventional Transradial Artery Access for Coronary Catheterization in Patients With STEMI (DR-STEMI) Rationale and Design of an International, Multicenter, Randomized Trial /

Distal Versus Conventional Transradial Artery Access for Coronary Catheterization in Patients With STEMI (DR-STEMI) Rationale and Design of an International, Multicenter, Randomized Trial /

Transradial access (TRA) constitutes the cornerstone for cardiac catheterization and is recommended by the multiple recent guidelines, irrespective of clinical presentation. The existing literature has evaluated distal transradial access (dTRA), as a feasible and safe approach in patients with chron...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Tsigkas Grigorios
Trigka-Vasilakopoulou Aikaterini
Apostolos Anastasios
Papafaklis Michael
Colletti Giuseppe
Mugnolo Antonio
Ruzsa Zoltán
Ungureanu Claudiu
Nikas Dimitrios
Xaplanteris Panagiotis
Gasparini Gabriele L
Sciahbasi Alessandro
Tsiafoutis Ioannis
Poulimenos Leonidas E
Didagelos Matthaios
Pappas Loukas
Stougiannos Pavlos
Hamilos Michalis
Ziakas Antonios
Timpilis Filippos
Karanasos Antonios
Moulias Athanasios
Sgueglia Gregory A
Aminian Adel
Iglesias Juan F
Michalis Lampros
Davlouros Periklis
Dokumentumtípus: Cikk
Megjelent: 2026
Sorozat:AMERICAN HEART JOURNAL 291
Tárgyszavak:
Klinikai orvostan
doi:10.1016/j.ahj.2025.08.007

mtmt:36293638
Online Access:http://publicatio.bibl.u-szeged.hu/37491
Leíró adatok
Tartalmi kivonat:Transradial access (TRA) constitutes the cornerstone for cardiac catheterization and is recommended by the multiple recent guidelines, irrespective of clinical presentation. The existing literature has evaluated distal transradial access (dTRA), as a feasible and safe approach in patients with chronic and acute coronary syndrome, excluding although patients presenting with ST- elevation myocardial infraction (STEMI).The current randomized clinical trial compares dTRA versus conventional TRA access in patients with STEMI undergoing coronary angiography and interventions regarding peri- and post-procedural characteristics.DR-STEMI is a prospective, open label, European, multicenter randomized-control trial which will include 554 patients (277 patients in each treatment arm). Patients with STEMI, will be screened on an all-comers basis for study inclusion and exclusion criteria, and those eligible will be allocated randomly (1:1), to dTRA versus TRA approach. The primary hypothesis of the study is that dTRA is non-inferior to conventional TRA regarding the required time between the puncture of the radial artery and wire crossing of the infarct-related artery (i.e., needle-to-wire time).Enrollment for the DR-STEMI trial began in May 2024, and as of April 15th, 2025, 309 patients have been enrolled in the study. Recruitment is expected to continue for approximately 12 months.clinicaltrials.gov: NCT05605288.
Terjedelem/Fizikai jellemzők:73-80
ISSN:0002-8703

Hasonló tételek